What’s driving high drug prices
– Patents and exclusivity keep branded drugs insulated from competition for years, delaying lower-cost generics and biosimilars.
– Pharmacy benefit managers (PBMs) negotiate rebates and fees between manufacturers and plans; their practices can obscure the true price and affect which drugs are favored on formularies.
– Price-setting by manufacturers for new therapies — especially specialty drugs — can push overall spending up quickly.
– Gaps in insurance benefit design (high deductibles, lack of caps on out-of-pocket costs) leave many patients exposed.
Policy levers being used
– Drug price negotiation: Policymakers are expanding tools that allow large public programs to negotiate prices directly with manufacturers for high-cost medicines, aiming to secure lower net prices.
– Inflation penalties and rebates: Programs that require manufacturers to rebate price increases above inflation to payers are being strengthened to discourage sudden list-price jumps.
– Insulin and select drug caps: Efforts to limit patient cost-sharing for essential medications like insulin and certain chronic therapies are gaining traction through legislation and insurer policies.
– Promotion of generics and biosimilars: Faster regulatory pathways and incentives to adopt lower-cost alternatives help increase competition and reduce prices.
– Transparency and PBM oversight: New rules and state actions are pushing for clearer reporting of list prices, rebates, and PBM practices to align incentives toward lower patient costs.
Practical steps patients can take today
– Ask about generics and biosimilars: Most drugs have lower-cost alternatives that are therapeutically equivalent. Request prescriber consideration of these options.
– Review your formulary before filling prescriptions: Insurance plans place drugs on tiers that determine copays.
If a prescribed drug is on a non-preferred tier, ask your clinician about alternatives or seek an exception.
– Shop prices and use comparison tools: Pharmacy price differences can be significant. Compare local pharmacies and online discount tools to find the best out-of-pocket price.
– Use manufacturer assistance and patient programs: For high-cost branded drugs, patient assistance foundations and manufacturer copay programs can bridge affordability gaps for eligible people.
– Talk to your pharmacist: Pharmacists can suggest therapeutic alternatives, point out savings programs, and help with prior authorizations or step therapy appeals.
– Consider mail-order and 90-day supplies: For chronic medications, longer fills or mail-order pharmacies can lower total costs and increase convenience.
– Check if biosimilars are available: For biologic therapies, biosimilars often offer substantial savings; ask whether switching is clinically appropriate.
What to watch
Policy shifts around negotiation authority, inflation penalties, and PBM oversight can change out-of-pocket dynamics for many patients. Meanwhile, continued innovation in specialty therapies will keep pressure on budgets.
Patient advocacy and proactive conversations with clinicians and pharmacists remain the most effective immediate tools for managing costs.
Being informed and persistent pays off. Review your plan’s drug coverage, ask for lower-cost alternatives, and use available assistance programs to limit spending without compromising care.